Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 5, 2018
Patent Application Number
15150999
Date Filed
May 10, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is related to crystalline forms of (S)-7-(1-(9H-purin-6-ylamino) ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one which is a PI3K inhibitor useful in the treatment of cancer and other diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
